Association between congenital toxoplasmosis and parent-reported developmental outcomes, concerns, and impairments, in 3 year old children

被引：19

作者：

Freeman K. ^{[1
,20
]}

Salt A. ^{[2
,20
]}

Prusa A. ^{[3
]}

Malm G. ^{[4
]}

Ferret N. ^{[5
]}

Buffolano W. ^{[6
]}

Schmidt D. ^{[7
,18
]}

Tan H.K. ^{[8
,20
]}

Gilbert R.E. ^{[8
,20
]}

Bessieres M.-H. ^{[14
]}

Dumon H. ^{[13
]}

Petersen E. ^{[18
]}

Paul M. ^{[9
]}

Hayde M. ^{[10
]}

Pollak A. ^{[10
]}

Wallon M. ^{[11
]}

Peyron F. ^{[11
]}

Romand S. ^{[12
]}

Thulliez P. ^{[12
]}

Franck J. ^{[13
]}

Dumon H. ^{[13
]}

Bastien P. ^{[13
]}

Issert E. ^{[13
]}

Marty P. ^{[15
]}

Pelloux H. ^{[16
]}

Fricker-Hidalgo H. ^{[16
]}

Bost-Bru C. ^{[16
]}

Evengard B. ^{[17
]}

Chemla C. ^{[19
]}

Semprini E.

Savasi V.

Gras L. ^{[20
]}

Rickett J. ^{[20
]}

Valenti L. ^{[20
]}

机构：

[1] Albert Einstein College of Medicine, Department of Epidemiology and Population Health, New York, NY

[2] The Neurodisability Service, Great Ormond Street Hospital for Children, Institute of Child Health, London

[3] Department of Pediatrics, Division of Neonatology and Intensive Care, Medical University of Vienna, Vienna

[4] Karolinska University Hospital, Huddinge, Stockholm

[5] CHU de NICE, Service Parasitologie - Mycologie, Hopital L'Archet II, 06202 Nice Cedex 3

[6] Perinatal Infection Unit, Dept. of Pediatrics, University of Naples Federico II, Naples

[7] Department of Parasitology, Staten Seruminstitut, Copenhagen

[8] Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, London

[9] University Medical Sciences, Poznan

[10] University Children's Hospital, Vienna

[11] Hôpital de la Croix Rousse, Lyon

[12] Institut de Peuriculture, Paris

[13] Hôpital de la Timone, CHU de Montpellier, Marseille

[14] Hôpital de Rangueil, Toulouse

[15] Hôpital de l'Archet, Nice

[16] Centre Hospitalier, Universitaire de Grenoble, Grenoble

[17] Huddinge Hospital, Stockholm

[18] Statenseruminstitut, Copenhagen

[19] Hôpital Maison Blanche, Reims

[20] Institute of Child Health, London

来源：

BMC Pediatrics | / 5卷 / 1期

关键词：

Toxoplasmosis; Infected Child; Neonatal Screening; Parental Concern; Parental Anxiety;

D O I：

10.1186/1471-2431-5-23

中图分类号：

学科分类号：

摘要：

Background: Information is lacking on the effects of congenital toxoplasmosis on development, behavior, and impairment in later childhood, as well as on parental concerns and anxiety. This information is important for counselling parents about the prognosis for an infected child and for policy decisions on screening. Methods: We prospectively studied a cohort of children identified by screening for toxoplasmosis in pregnant women or neonates between 1996 and 2000 in ten European centers. At 3 years of age, parents of children with and without congenital toxoplasmosis were surveyed about their child's development, behavior, and impairment, and about parental concerns and anxiety, using a postal questionnaire. Results: Parents of 178/223 (80%) infected, and 527/821 (64%) uninfected children responded. We found no evidence that impaired development or behavior were more common in infected children, or that any potential effect of congenital toxoplasmosis was masked by prenatal treatment. Parents of infected children were significantly more anxious and reported more visual problems in their children. Conclusion: On average, children aged three to four years with congenital toxoplasmosis identified by screening and treated during infancy in this European setting had risks of abnormal development and behavior similar to uninfected children. Parental anxiety about infected children needs to be addressed by clinicians. Future studies with longer follow up and clinician-administered assessments may be better able to detect any subtle differences in child outcomes. © 2005 Freeman et al; licensee BioMed Central Ltd.

引用

页数：10

共 21 条

[1]

Gilbert R.E., Peckham C.S., Congenital toxoplasmosis in the United Kingdom: To screen or not to screen?, J. Med. Screen., 9, pp. 135-141, (2002)

[2]

Koppe J.G., Loewer Sieger D.H., de Roever Bonnet H., Results of 20-year follow-up of congenital toxoplasmosis, Lancet, 1, pp. 254-256, (1986)

[3]

Wilson C.B., Remington J.S., Stagno S., Reynolds D.W., Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection, Pediatrics, 66, pp. 767-774, (1980)

[4]

Roizen N., Swisher C.N., Stein M.A., Hopkins J., Boyer K.M., Holfels E., Mets M.B., Stein L., Patel D., Meier P., Et al., Neurologic and developmental outcome in treated congenital toxoplasmosis, Pediatrics, 95, pp. 11-20, (1995)

[5]

Paul M., Petersen E., Pawlowski Z.S., Szczapa J., Neonatal screening for congenital toxoplasmosis in the Poznan region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots, Pediatr. Infect. Dis. J., 19, pp. 30-36, (2000)

[6]

Gilbert R., Gras L., Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii, BJOG, 110, pp. 112-120, (2003)

[7]

Salt A., Freeman K., Prusa A., Ferret N., Buffolano W., Malm G., Petersen E., Gilbert R.E., Determinants of response to a parent questionnaire about development and behavior in 3 year olds: European multicenter study of congenital toxoplasmosis, BMC Pediat, 5, 1, (2005)

[8]

Harris B., Requirements for scoring drawings, item by item, Children's Drawings As Measures of Intellectual Maturity, pp. 246-263, (1963)

[9]

Marteau T.M., Cook R., Kidd J., Michie S., Johnston M., Slack J., Shaw R., The psychological effects of false positive results in prenatal screening for fetal abnormality: A prospective study, Prenat. Diagn., 12, pp. 205-214, (1992)

[10]

Holland G.N., Ocular toxoplasmosis: A global reassessment. Part II: Disease manifestations and management, Am. J. Ophthalmol., 137, pp. 1-17, (2004)

← 1 2 3 →